Laddar...
Disease modeling of a mutation in α‐actinin 2 guides clinical therapy in hypertrophic cardiomyopathy
Hypertrophic cardiomyopathy (HCM) is a cardiac genetic disease accompanied by structural and contractile alterations. We identified a rare c.740C>T (p.T247M) mutation in ACTN2, encoding α‐actinin 2 in a HCM patient, who presented with left ventricular hypertrophy, outflow tract obstruction, and a...
Sparad:
| I publikationen: | EMBO Mol Med |
|---|---|
| Huvudupphovsmän: | , , , , , , , , , , , , , , , , , , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
John Wiley and Sons Inc.
2019
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6895603/ https://ncbi.nlm.nih.gov/pubmed/31680489 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.201911115 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|